Bezafibrate

4 trials 1 recruiting CCardiology

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

2 Sponsors

13 Countries

Phase III

Phase II

Phase III: 2 Phase II: 2

Indications tested

Primary biliary cholangitis 2

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 2 Intercept Pharmaceuticals Inc. 2

All trials

4 total

Efficacy and safety of bezafibrate 400 mg and bezafibrate 200 mg as adjunctive treatments in patients with primary biliary cholangitis and n… Recruiting

2023-504086-23-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Double blind, multicentric, randomized, placebo-controlled trial, evaluating the efficacy of 24-month of bezafibrate in primary sclerosing c… Ended

2024-511658-28-01 Phase III 1 country Assistance Publique Hopitaux De Paris
Study to determine if the investigational drug obeticholic acid (also known as OCA) in combination with the investigational drug bezafibrate… Ended

2024-513584-77-00 Phase II 1 country Intercept Pharmaceuticals Inc.
A study to learn about the effects and safety of obeticholic acid in combination with bezafibrate in participants with primary biliary chola… Ended

2024-513762-18-00 Phase II 12 countries Intercept Pharmaceuticals Inc.

Showing 1–4 of 4 trials

← All drugs A–Z